Sclerosis
Biogen Idec Inc. is focused on developing treatments in the areas of oncology, immunology, and neurology. Its product roster includes best-selling Avonex, the most popular drug for the treatment of relapsing multiple sclerosis.
Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). The company focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Their NanoCrystal® technology is a proven innovation for poorly water-soluble compounds, manufactured to the nanoscale it has five licensed products commercialized to date.